Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi Van Dang

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 2, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Cancer Discovery|November 2, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 1, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Cancer Research|November 2, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Molecular Cancer Research : MCR|November 3, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Nature Cancer|June 4, 2021
Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinomaShuai Wu, Takeshi Fukumoto, Jianhuang Lin, et al.
The Lancet. Oncology|December 7, 2017
Future cancer research priorities in the USA: a Lancet Oncology CommissionElizabeth M Jaffee, Chi Van Dang, David B Agus, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 2, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Cancer Discovery|November 2, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 1, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Cancer Research|November 2, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Molecular Cancer Research : MCR|November 3, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Nature Cancer|June 4, 2021
Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinomaShuai Wu, Takeshi Fukumoto, Jianhuang Lin, et al.
The Lancet. Oncology|December 7, 2017
Future cancer research priorities in the USA: a Lancet Oncology CommissionElizabeth M Jaffee, Chi Van Dang, David B Agus, et al.
Pageof 3